Herley Industries, Inc. Board of Directors Concludes Strategic Alternatives Review To Discuss Conclusions with Investors at a July 22, 2009 Conference in New York

LANCASTER, Pa., July 22 /PRNewswire-FirstCall/ -- The Board of Directors for Herley Industries, Inc. (Nasdaq: HRLY ) today announced sweeping changes to its top management leadership. Myron Levy Replaced as Chairman and CEO David Lieberman named Chairman of The Boar...

California Expert Panel Concludes Bisphenol A is Not a Reproductive or Developmental Toxicant

ARLINGTON, Va., July 15 /PRNewswire-USNewswire/ -- "The American Chemistry Council (ACC) is pleased that a panel of independent scientific experts convened by the State of California concluded today that bisphenol A is not a reproductive or developmental toxicant. After a thorough revie...

Blue Cross Blue Shield of Michigan Concludes Autism Lawsuit with Settlement Focused on Families Who Received Early Intervention Services, Not Attorneys

DETROIT, June 19 /PRNewswire/ -- One month after announcing that it would voluntarily offer its customer groups the ability to purchase coverage for intensive early intervention treatment for autism beginning July 1, Blue Cross Blue Shield of Michigan said today it has concluded a lawsuit involvin...

The PDS ToxData, ReproData, and PathData User Group Meeting for 2009 Concludes - User Presentations, In-Depth Workshops and U2U Networking Dominate Agenda

State of the Company, new users and innovations in products at PDS continue on excellent track. Mount Arlington, NJ (PRWEB) May 7, 2009 -- PDS Pathology Data Systems, Ltd. , developers of the integrated software systems ToxData®, ReproData®, and PathData® ...

Health System Collapse Requires International Intervention, Concludes PHR Report

An international team of doctors and human rights advocates convened by Physicians for Human Rights (PHR) to conduct an emergency assessment of Zimbabwe's health crisis has found the health system is in utter collapse. The collapsed health care system threatens the people of Zimbabwe and in the e...

TomoTherapy Concludes Treatment Quality Challenge

TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S. cancer center that could surpass the quality of a he...

NIH study concludes next week's summer chorus camp for seniors improves quality of life

(St. Mary's City, MD) June 12, 2008Encore Creativity for Older Adults and St. Mary's College of Maryland (SMCM) will co-host Encore's first Summer Chorale Camp Tuesday, June 17, through Saturday, June 21, at SMCM. Encore executive director Jeanne Kelly helped lead a study about senior citizens, a...

Global menopause summit concludes HRT is safe for healthy women entering menopause

Global menopause summit concludes HRT is safe for healthy women entering the menopause. HRT in the early postmenopausal period is safe, and healthy women going through the first few years of the menopause who need HRT to relieve symptoms should have no fears about its use. This is the conclusio...

Study concludes no racial disparities in long-term outcomes in recipients of liver transplants

CHICAGO (May 19, 2008) New research published in the Journal of the American College of Surgeons shows long-term survival and liver rejection rates are equivalent for African-American liver transplant patients as compared with patients of other races. The study also suggests that although other f...

Broad Stakeholder Coalition Concludes that the 'Pathway for Biosimilars Act' Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients

WASHINGTON, March 14 /PRNewswire-USNewswire/ -- The Coalition for a Competitive Pharmaceutical Market (CCPM) -- the organization representing a broad range of pharmaceutical stakeholders, including large national employers, insurers, pharmacies and generic drug manufacturers -- strongly u...

concludes in Medical Technology

Phase IV Multi-center Clinical Study of Kutai Concludes in Nanjing

REVIEW OF RESULTS CONFIRM SAFETY AND EFFICACY FOR ROOM TEMPERATURE STORAGE NANTONG CITY, China, March 24 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) is pleased to announce that its patented version of Cisatracurium besylate, a pre-surgical skeletal muscle relaxant...

Cytopia Concludes Phase I Oral Trial for Vascular-Disrupting Agent, CYT997

MELBOURNE, Australia, Feb.5 /PRNewswire/ -- Cytopia Limited (ASX: CYT) has successfully concluded dose-escalation in its oral Phase I study for CYT997, the company's anticancer vascular-disrupting agent (VDA). The primary objectives of this safety and tolerability study have been achieved. T...

Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests

FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity than Other Rapid HBSAG Tests and FirstVue(TM) '...and was the preferred test in all phases of this evaluation' CORAL SPRINGS, Fla., Oct. 13 /PRNewswire/ -- AT First Diagnostic LLC an emerging worldwide m...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

SOUTH SAN FRANCISCO, Calif. and ALLSCHWIL, Switzerland, June 20 /PRNewswire/ -- Actelion Ltd (SWX: ATLN) announced today that data published in The Lancet(1) show that, in mildly symptomatic pulmonary arterial hypertension (PAH) patients (WHO functional class II - WHO FC II), bosentan (Traclee...

Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial

SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the company and the U.S. Food and Drug Administration (FDA) have reached agreement on the phase 3 registration trial of Bronchitol for bronchiectasis via the Special Protocol Ass...

Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury

Company plans to begin Phase IIb study in the first half of 2008 HOPKINTON, Mass., Jan. 7 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc., (Nasdaq: ALSE ), announced today that it has concluded enrollment in the Phase I/IIa clinical trial of Cethrin in acute spinal cord injury (SC...

FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)

WILMINGTON, Del., Dec. 10 /PRNewswire-FirstCall/ -- The US Food and Drug Administration (FDA) today issued its final assessment of two small, open, long-term, clinical studies in patients with gastro-esophageal reflux disease (GERD), comparing anti-reflux surgery with either omeprazole (SOPRAN...

MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy

BOTHELL, WA – June 25 – MediQuest Therapeutics, Inc., a specialty pharmaceutical company focused on developing therapies for inflammatory and infectious diseases, today announced the completion of its confirmatory phase III study of Vascana – a topical formulation designed to tre...

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

...ening now that HPV vaccination has been adopted. Dr. Stewart Massad, the paper's lead author and a member of the SGO Forum's Organizational Committee, concludes that until population-based data on the performance of cytology, HPV testing and alternate screening or triage interventions become available, modific...

Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study

... - 12-week study concludes that new cosmeceutical improves skin barrier function, erythema and lesions...nt to physicians interested in rosacea." The 12-week, open-label study concludes that Pyratine XR(TM) (0.125% furfuryl tetrahydropyranyladenine) improved sk...

concludes in Biological News

'Hobbit' fossils represent a new species, concludes University of Minnesota anthropologist

University of Minnesota anthropology professor Kieran McNulty (along with colleague Karen Baab of Stony Brook University in New York) has made an important contribution toward solving one of the greatest paleoanthropological mysteries in recent history -- that fossilized skeletons resembling a myt...

Major study concludes that global warming is killing off coral

If world leaders do not immediately engage in a race against time to save the Earth's coral reefs, these vital ecosystems will not survive the global warming and acidification predicted for later this century. That is the conclusion of a group of marine scientists from around the world in a major ...

Antioxidant users don't live longer, analysis of studies concludes

The vitamin industry has long touted antioxidants as a way to improve health by filling in gaps in diet, but a new review of studies found no evidence that the nutrition supplements extend life. Worse, the review authors said that some antioxidants could increase risk for death. The reviewers w...

Major WHO study concludes calcium supplements can reduce complications during pregnancy

For more than a year, researchers watched patiently as a few computer-simulated HIV protease molecules squirmed into more than 15,000 slightly different shapes. In real time, this contortion takes only a fraction of a second. In the end, however, this suspended animation paid off, as the simulation...

1 in 6 health workers won't report in flu pandemic -- study by Ben-Gurion U. researchers

...re of this threat and its associated challenges, including worldwide morbidity, mortality and social disruption," explains Dr. Balicer. The study concludes that in the context of pandemic influenza planning, the EPPM provides a useful framework to inform nuanced understanding of baseline levels of and ga...

Placenta-derived stem cells may help sufferers of lung diseases

...nflammatory effects. "Our findings suggest that fetal membrane-derived cells may prove useful for cell therapy of fibrotic diseases in the future," concludes Dr. Parolini. Dr. Cesar Borlongan, of the University of South Florida and associate editor for Cell Transplantation, notes that the present study a...

Life on Earth came from other planets

... Life on Earth came from other planets. So concludes a major scientific article which will appear in the inaugural issue of the ...0 research reports published in prestigious scientific journals, Dr. Joseph concludes that innumerable microbes, and their DNA, survived the cataclysm that wroug...

UK Identity and Passport Service and IBM Sign 7-year National Biometric Identity Service (NBIS) Contract

...re from Sagem Securite (SAFRAN Group). The contract between IPS and IBM was signed in May 2009. Notes to Editors Today's announcement concludes the NBIS contract award made in the Home Office statement on the 7th April 2009: http://nds.coi.gov.uk/content/Detail.aspx?NewsAreaId=2&Release...

When it comes to brain damage, blankets take the place of drugs

...ally cooled patients. Shivering subsided when the blankets were replaced. Though warming the skin does not reduce shivering in all patients, Kramer concludes that "its simplicity, low cost, widespread availability, lack of adverse effects, and the potential to avoid sedation ... make it an attractive treatm...

ADA releases updated position paper on vegetarian diets

... CHICAGO The American Dietetic Association has released an updated position paper on vegetarian diets that concludes such diets, if well-planned, are healthful and nutritious for adults, infants, children and adolescents and can help prevent and treat chronic disease...

concludes in Biological Technology

Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company's Sales and Promotional Practices

Company Finalizes Previously Announced Agreement with U.S. Attorney's Office for Eastern District of Pennsylvania and U.S. Department of Justice Settles State Cases with Connecticut and Massachusetts FRAZER, Pa., Sept. 29 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) announ...

West Concludes Agreement with Nektar

- Expects to Recover Investments in Dedicated Assets - LIONVILLE, Pa., Feb. 13 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that it has concluded an agreement with Nektar Therapeutics, Inc., relating to the manufacture and assembly of comp...

Workforce Alliance Concludes Three-Year Biotech Training Program

WEST PALM BEACH, Fla., Jan. 9 /PRNewswire/ -- Workforce Alliance, the non- profit organization that manages job training programs in Palm Beach County, is closing a grant program that enabled over ninety professionals to upgrade their skills and prepare for employment in the life sciences and ...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

...0 per cent decline in the value of biotech firms, means that outright acquisitions rather than complex licensing deals are an attractive proposition," concludes Gopinathan. To participate in this briefing, please email Patrick Cairns at patrick.cairns@frost.com " target="_new"> patrick.cairns@frost....

Information warfare in the 21st century: Ideas are sometimes stronger than bombs

...ation warfare against terrorist organizations ought to be instigated and on the attack, and should continue even when military warring has ended. Thus concludes a new study by Dr. Yaniv Levyatan of the Ezri Center for the Study of Iran and the Gulf at the University of Haifa, which was published in the Nationa...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

...ering-Plough II-74 Bayer to Stop Sale of Viadur - A Drug for Prostate Cancer II-74 Sagemark Embarks on Radiation Therapy Venture II-75 RTS concludes Californian Radiation Therapy Center Acquisition II-75 Radiation Therapy Takes Over a North Carolina Treatment Center II-75 DRAXIMAGE and Med ...

EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements

... The European Food Safety Authority (EFSA) concludes no safety concerns for the use of chromium picolinate in food supplements, in response to Nutrition 21's Application to market Chromax(R) chromium pic...

Dey L.P. to Market EMSAM(R) Skin Patch for Treatment of Major Depressive Disorder

...y was marketed and distributed by Bristol-Myers Squibb through a commercialization agreement. The transfer of distribution, marketing and sales to Dey concludes the three-year agreement with Bristol-Myers. Manufactured by Mylan subsidiary Mylan Technologies Inc. (MTI), EMSAM is a registered trademark of Somers...

Information warfare in the 21st century: Ideas are sometimes stronger than bombs

...ation warfare against terrorist organizations ought to be instigated and on the attack, and should continue even when military warring has ended. Thus concludes a new study by Dr. Yaniv Levyatan of the Ezri Center for the Study of Iran and the Gulf at the University of Haifa, which was published in the Nationa...

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009

...tled "Events and Presentations" on the left side of the screen. A replay of each webcast will available approximately one hour after the live webcast concludes and will remain available for 30 days. About Cadence Pharmaceuticals, Inc. Cadence Pharmaceuticals is a biopharmaceutical company focused on ...

concludes in Biological Definition

Alfred Russel Wallace

...uction of Species" (1855) , in which he gathers and enumerates general observations regarding the geographic and geologic distribution of species, and concludes that "Every species has come into existence coincident both in space and time with a closely allied species." The paper was a foreshadowing of the mo...